The Alberta Dental Society of Anesthesiology (ABDSA) Speaker Series
The upcoming speakers will be presenting on various Sedation topics. Please click on the link or scroll down the page to learn more about the topic, speaker and event details.
Speaker
Dr. Rohit Bedi
BDS, PGDipHsc (Akl), NZREX
The Use of Target Controlled Infusions
with Propofol and Remifentanil for
Procedural Sedation in Dentistry
May 15th, 2025 - 6:00 - 8:00 PM Via Zoom.
This webinar offers an overview of target-controlled infusions for procedural sedation in dentistry. You’ll learn about the advantages of TCI compared to traditional methods like intermittent bolusing, including enhanced control of sedation levels, reduced complication risks, and improved patient outcomes with shorter recovery times. Additionally, TCI provides predictability in the complex patient cohorts commonly encountered in the modern dental practice. An opportunity to learn how TCI can enhance your ability to deliver safe and effective moderate sedation in the dental setting.
Learning objectives:
-
Understand how TCI minimizes pharmacokinetic and pharmacodynamic variability in patients for safer and more predictable sedation.
-
Learn how processed EEG or BIS monitoring using the bi spectral index can be used to make real-time adjustments with TCI.
-
Discover the evolution of TCI algorithms, from older approaches to the advanced algorithms we use today.
-
Learn about the advantages of short-acting drugs for IV sedation in ambulatory settings.
-
Understand the training and team requirements for the safe use of TCI in an outpatient setting.
About Speaker
Dr. Rohit Bedi has a special interest in providing care using advanced intravenous sedation techniques to help treat patients with extreme dental anxiety and complex needs. He routinely lectures for the New Zealand Dental Association, the New Zealand Society for Sedation in Dentistry.
He consults for the Dental Council of New Zealand for sedation related matters and is actively involved in international education and research around advanced sedation methodology and patient safety. He is currently involved with research projects on Target Controlled Infusions using Propofol and Remifentanil for the delivery of
Total Intravenous Sedation at the University of Alberta, Canada.
He has extensive experience in clinical sedation, lecturing, research, and committee involvement at both
national and international levels
Sign Up for Our Speaker
"*" indicates required fields